We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > SSRIs

News List

Certain Antidepressants Appear to Curb Severe COVID-19 Drugs
November 17, 2021
Certain commonly prescribed antidepressants appear to substantially lower the risk of dying among seriously ill COVID-19 patients, a large new study indicates.
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19 Drugs
November 16, 2021
For patients with COVID-19, selective serotonin reuptake inhibitors (SSRIs) are associated with a reduced relative risk for mortality, according to a study published online Nov. 15 in JAMA Network Open.
Weighing risks and benefits of drug treatment for major depression worldpharmanews
June 20, 2019
Weighing risks and benefits of drug treatment for major depression.